Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IBRX
#815
ImmunityBio, Inc. Common Stock
9.7
8
+3.93%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+3.93%
Changement Mensuel
+63.00%
Evolution sur 6 mois
+312.66%
Changement Annuel
+213.46%
Clôture Précédente
9.4
1
Open
9.7
8
Bid
Ask
Low
9.7
8
High
9.7
8
Volume
189
Marchés
Actions des Marchés US
Soins de Santé
IBRX
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
Nouvelles
Simon, director, sells ImmunityBio (IBRX) shares worth $900k
ImmunityBio completes enrollment in bladder cancer trial
ImmunityBio Investors Rally Behind Cancer Trial Milestone - ImmunityBio (NASDAQ:IBRX)
Netflix and Palantir among market cap stock movers on Wednesday
ImmunityBio Supersedes Expectations With Fivefold Revenue Increase - ImmunityBio (NASDAQ:IBRX)
AMD and Keysight Technologies among market cap stock movers on Tuesday
Tesla, Oracle among market cap stock movers on Monday
H.C. Wainwright raises Immunitybio stock price target to $15
ImmunityBio (IBRX) Reports Q4 Loss, Beats Revenue Estimates
American Express, Oracle among market cap stock movers on Monday
Immunitybio Inc earnings beat by $0.05, revenue topped estimates
ImmunityBio Shares Surge On 700% Revenue Growth Driven By Anktiva - ImmunityBio (NASDAQ:IBRX)